Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccine manufacturing
Pharma
After cuts, Novavax's Q4 performance startles investors
As Novavax emerges from its “transition year” in 2023, the vaccine maker is still raising concerns among Wall Street investors in early 2024.
Fraiser Kansteiner
Feb 28, 2024 9:38am
Daiichi Sankyo secures COVID vaccine supply pact in Japan
Nov 17, 2023 9:45am
Micron snags big Gates grant to produce needle-free vaccines
Nov 16, 2023 12:53pm
Pfizer axes 200 jobs in Michigan amid COVID cost-cutting spree
Nov 3, 2023 10:23am
Pfizer takes $5.6B in Paxlovid, Comirnaty inventory write-offs
Oct 31, 2023 10:12am
Gates Foundation lays out $40M for African mRNA shot production
Oct 9, 2023 2:27pm